Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Canakinumab Study Fails to Meet Primary Endpoint

americanpharmaceuticalreviewNovember 17, 2020

Tag: canakinumab , COVID-19 , SOC , CAN-COVID

PharmaSources Customer Service